General Membership Meeting Scheduled for August 7th
Please join us for our next General Membership meeting on August 7th from 8-9PM. Adam Rzetelny, Ph.D., will present information…
General
New Clinical Guidance: Stimulant Use
On behalf of the NYSDOH AI, lead authors Drs. Judith Griffin, Sara Lorenz Taki, and Timothy Wiegand, with the Substance Use…
Methadone Reform Conference: September 2023
Dear colleagues, We are delighted to invite you to the upcoming conference, “Liberating Methadone: Building a Roadmap and Community for…
Methadone Treatment in Primary Care: Experience from Ontario, Canada 1980-2021
Update: June 5, 2023: Slides and Recording Now available. Download Slides Watch Webinar Webinar – Wednesday, May 31st @ 7pm…
New OASAS Medical Advisory Panel (MAP) Xylazine Guidance
OASAS has posted the new OASAS Medical Advisory Panel (MAP) Xylazine Guidance document. Please share widely with your staff. Please…
Pilot Funding Opportunity: One Year Up to $75,000 for Research
One year of pilot funding of up to $75,000 for research into chronic pain and opioid use disorder IMPOWR-ME is…